Type 2 diabetes Trials in Etobicoke, Canada
Conditions / Type 2 diabetes / Etobicoke, Canada
Type 2 diabetes is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06131372 | A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo | COMPLETED | PHASE2 |
| NCT00255645 | G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study) | TERMINATED | — |
| NCT02019264 | A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors | COMPLETED | PHASE4 |
| NCT01609582 | Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease | TERMINATED | PHASE3 |
| NCT00673231 | Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin | COMPLETED | PHASE3 |
| NCT00261352 | GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate | TERMINATED | PHASE3 |
| NCT07157384 | REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring When Added to Low-calorie Meal Replacement and Diabetes Self-management Education | NOT_YET_RECRUITING | NA |
| NCT00263276 | A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 |
| NCT01768559 | Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients | COMPLETED | PHASE3 |
| NCT00251953 | GALLANT 8 Tesaglitazar Add-on to Metformin | TERMINATED | PHASE3 |